Definitive Contract HHSO100200700029C
Award Date
1/17/07
Potential Completion Date
2/26/17
Potential Value
$137M
Ultimate Awardee
Not listed
NAICS Category
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Philadelphia, PA 19120, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award with ID HHSO100200600011C, made by the Office of the Assistant Secretary for Preparedness and Response (a civilian agency) to the vendor Glaxosmithkline Holdings (Americas) Inc. The contract is for DRUGS AND BIOLOGICALS under the PANDEMIC INFLUENZA PREPAREDNESS major program, with a Definitive Contract type and Cost No Fee pricing. The contract has a ceiling value of $72,766,563.54 and an ultimate completion date of April 30, 2015. There was no set-aside used for...
This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to GlaxoSmithKline, LLC, a pharmaceutical company, under the Pandemic Influenza Preparedness and Response 2012-2016 contract. The contract is for the production of non-GMP influenza vaccine plots at a firm fixed price of $149,412.00. The award supports ASPR's broader efforts for pandemic influenza preparedness and response, including disease...
This federal contract award provides $4,002,243.15 in funding to Glaxosmithkline, LLC, a pharmaceutical company, for the acquisition of medical countermeasures (MCMs) and pandemic influenza preparedness and response under a new solicitation from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS-BARDA). The contract is a delivery order issued under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery, indefinite...
This federal contract award establishes services for H5 pandemic readiness through the acquisition of medical countermeasures (MCMs) for pandemic influenza and emerging diseases preparedness and response. The contract, valued at $94,587,688.20, was awarded to the prime contractor Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) with the Department of Health and Human Services'...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the prime contractor Glaxosmithkline, LLC (doing business as Glaxosmithkline). The $977,025.74 fixed-price delivery order contract supports the Pandemic Influenza Preparedness and Response 2016-2021 program and is for the provision of pharmaceutical products and services related to disease prevention and treatment. Glaxosmithkline, a global...
This is a $533,988.00 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to the pharmaceutical company Glaxosmithkline, LLC. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 IDIQ, which provides for the acquisition of medical countermeasures for pandemic influenza preparedness and response efforts. The contract does not have a set-aside designation....
This is a delivery order award to Glaxosmithkline, LLC under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery/indefinite quantity (IDIQ) contract with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The $2,812,228.00 fixed-price order is for the production of clinical lots of a CGMP (current good manufacturing practice) influenza vaccine. This supports the Acquisition of Medical...
This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
This is a $69,857,670.45 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for 2016 pandemic influenza preparedness efforts. The contract has a completion date of February 28, 2017 and was awarded on December 18, 2015. There was no set-aside designation used. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various federal agencies,...
This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company. The contract has a ceiling value of $18,161,555.00 and is part of the Pandemic Influenza Preparedness and Response 2016-2021 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The purpose of this contract is to conduct a clinical study for the...